We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TMO market cap is 218.13B. The company's latest EPS is USD 15.7220 and P/E is 36.39.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 10.71B | 10.69B | 10.57B | 10.89B | 10.35B |
Operating Income | 1.56B | 1.58B | 1.86B | 1.85B | 1.66B |
Net Income | 1.29B | 1.36B | 1.72B | 1.63B | 1.33B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 25.96B | 32.22B | 39.21B | 44.92B | 42.86B |
Operating Income | 4.59B | 7.79B | 10.03B | 8.39B | 6.86B |
Net Income | 3.7B | 6.38B | 7.73B | 6.95B | 6B |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 94.66B | 94.11B | 97.06B | 98.73B | 97.1B |
Total Liabilities | 52.23B | 50.19B | 51.59B | 51.88B | 51.47B |
Total Equity | 42.31B | 43.8B | 45.35B | 46.72B | 45.5B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 58.38B | 69.05B | 95.12B | 97.15B | 98.73B |
Total Liabilities | 28.71B | 34.55B | 54.15B | 53.01B | 51.88B |
Total Equity | 29.68B | 34.51B | 40.86B | 44.03B | 46.72B |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 729M | 2.27B | 4.68B | 8.41B | 1.25B |
Investing | -3.14B | -3.59B | -4.77B | -5.14B | -2.03B |
Financing | -2.59B | -4.05B | -2.19B | -3.62B | -1.82B |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 4.97B | 8.29B | 9.31B | 9.15B | 8.41B |
Investing | -1.49B | -1.51B | -21.93B | -2.16B | -5.14B |
Financing | -3.12B | 959M | 6.58B | -2.81B | -3.62B |
Market Cap | 218.13B |
Price to Earnings Ratio | 36.39 |
Price to Sales Ratio | 5.09 |
Price to Cash Ratio | 27.01 |
Price to Book Ratio | 4.66 |
Dividend Yield | 0.26% |
Shares Outstanding | 381.31M |
Average Volume (1 week) | 1.38M |
Average Volume (1 Month) | 1.29M |
52 Week Change | 8.38% |
52 Week High | 603.82 |
52 Week Low | 415.60 |
Spread (Intraday) | 28.95 (4.82%) |
Company Name | Thermo Fisher Scientific Inc |
Address |
108 lakeland ave dover, delaware 19901 |
Website | https://www.thermofisher.com |
Industry | meas & controlling dev, nec (3829) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions